Stomach Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
820
|
55
|
0.600 |
None |
|
0 |
1
|
|
|
Benign neoplasm of stomach
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
17
|
|
0.300 |
None |
|
0 |
|
|
|
Neoplasm of uncertain or unknown behavior of stomach
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
17
|
|
0.300 |
None |
|
0 |
|
|
|
Lung Neoplasms
|
group |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1486
|
39
|
0.300 |
None |
|
0 |
|
|
|
Carcinoma in situ of stomach
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
19
|
|
0.300 |
None |
|
0 |
|
|
|
Hereditary Diffuse Gastric Cancer
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
312
|
119
|
0.300 |
None |
|
0 |
|
|
|
Bronchioloalveolar Adenocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
136
|
5
|
0.100 |
None |
|
0 |
|
|
|
Somatic mutation
|
phenotype |
|
Cell or Molecular Dysfunction
|
151
|
|
0.100 |
None |
|
0 |
|
|
|
Increased level of L-fucose in urine
|
phenotype |
|
Finding
|
14
|
|
0.100 |
None |
|
0 |
|
|
|
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.310 |
limited |
1.000 |
1 |
|
2018 |
2018 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.310 |
None |
1.000 |
1 |
|
2018 |
2018 |
Cerebrovascular accident
|
group |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1658
|
591
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Acute Cerebrovascular Accidents
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
155
|
2
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Myocardial Ischemia
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
756
|
103
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Endometrial adenocarcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
212
|
5
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
Endometrial Endometrioid Adenocarcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
53
|
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
endometrial adenoacanthoma
|
disease |
|
Neoplastic Process
|
7
|
12
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
Lung diseases
|
group |
Respiratory Tract Diseases
|
Disease or Syndrome
|
700
|
50
|
0.200 |
None |
1.000 |
1 |
|
2002 |
2002 |
Allergic Conjunctivitis
|
disease |
Eye Diseases; Immune System Diseases
|
Disease or Syndrome
|
38
|
2
|
0.200 |
None |
1.000 |
1 |
|
2003 |
2003 |
Reperfusion Injury
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Injury or Poisoning
|
300
|
|
0.200 |
None |
1.000 |
1 |
|
2002 |
2002 |
Other ureteric obstruction
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Anatomical Abnormality
|
52
|
|
0.200 |
None |
1.000 |
1 |
|
2003 |
2003 |
Fibrinogen assay
|
phenotype |
|
Laboratory Procedure
|
55
|
143
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Fibrinogen, CTCAE
|
phenotype |
|
Finding
|
26
|
63
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Platelet Count measurement
|
phenotype |
|
Laboratory Procedure
|
265
|
457
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
fibrinogen activity
|
phenotype |
|
Molecular Function
|
26
|
63
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |